Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer

Clinical trial NCT06274879 · RECRUITING

Trial details

NCT number: NCT06274879
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bile Duct Cancer

Start date: 2026-05-20
Primary completion: 2029-12-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.